News
Fujirebio today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s ...
The blood test measures two subtypes of tau and amyloid proteins, which can indicate the presence of amyloid plaque in the ...
Today, the FDA's approved the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, marking a pivotal moment in the fight against ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results